OPRK1 and hepatocellular carcinoma: Our results show that morphine targeting MOR has no anti-tumor effects on HCC cells in vivo and in vitro, while KOR specific agonist U50488h effectively inhibited the proliferation, migration and apoptosis of HCC cells in vivo and in vitro, suggesting that KOR may be a potential tumor suppressor gene.